Christopher C. Mader

Discovering the anticancer potential of non-oncology drugs by systematic viability profiling

Steven M. Corsello, Rohith T. Nagari, Ryan D. Spangler et al. · Nature Cancer · 2020 · 831 citations · Full text

Tumor Biology, Systematic Viability Profiling, Medicine +12

Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity

Gabriela Sarti Kinker, Alissa Greenwald, Rotem Tal et al. · Nature Genetics · 2020 · 434 citations · Full text

Tumor Heterogeneity, Cellular Heterogeneity, Medicine +6

Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation

Matthew G. Oser, Hideki Yamaguchi, Christopher C. Mader et al. · The Journal of Cell Biology · 2009 · 355 citations · Full text

An EGFR–Src–Arg–Cortactin Pathway Mediates Functional Maturation of Invadopodia and Breast Cancer Cell Invasion

Christopher C. Mader, Matthew G. Oser, Marco Magalhaes et al. · Cancer Research · 2011 · 286 citations · Full text

Cytoskeleton, Actin Polymerization, Cancer Biology +20

Immunomodulatory spherical nucleic acids

Aleksandar F. Radovic‐Moreno, Natalia Chernyak, Christopher C. Mader et al. · Proceedings of the National Academy of Sciences · 2015 · 247 citations · Full text